[Lite Strategy Announces FY2026 Results, Holding 832,716 LTC] According to a report by Jinse Finance on September 29, citing GlobeNewswire, Nasdaq-listed company Lite Strategy (Ticker: LITS, formerly MEI Pharma) announced its fiscal year 2026 results (ending June 30). The company is the first U.S.-listed firm to adopt Litecoin (LTC) as its primary treasury reserve asset. During the fiscal year, it deployed $100 million to purchase LTC, holding 832,716 LTC as of June 30, making it the largest LTC holder among publicly listed companies globally. As of the end of the period, total assets stood at $42.7 million, with no debt. The company initiated a $25 million stock buyback program, repurchasing approximately 6.4 million shares (17% of outstanding shares) as of September 22, narrowing the NAV discount from around 40% to the lower range of 20%.